Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions

NCT00960479 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Ribavirin 200 mg Oral Capsule (Geneva Pharmaceutical, U.S.A.)
DRUG: Rebetol 200 mg Oral Capsule (Schering Corporation, U.S.A.)

Sponsor

Sandoz